Organogenesis Holdings Azioni (NASDAQ: ORGO)

Ultime notizie per Organogenesis Holdings (NASDAQ:ORGO) Azioni

Organogenesis Hldgs

Organogenesis Holdings

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.

Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) experienced a sharp drop in sales in the Chinese domestic car market during the week of June 30 to July 6, 2025.
Check out the current price of <a href="https://benzinga.com/quote/tsla">TSLA stock here</a>.
What Happened: The EV giant recorded 5,010 new insured registrations in China, according to data compiled by influencer Roland Pircher on social media platform X on Tuesday.
The registrations this week dropped 75.8% from the preceding week's 20.7K registrations. Tesla sales are down 22.9% from the same time last year. However, the sales are up over 38% compared to Q2 2025.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">In China, 5010 Tesla insurance registrations were reported for the week of June 30 to July 6. &#x1f1e8;&#x1f1f3; The week is down 75.8% from last week and -22.9% year-over-year. The quarter is +38.8% QoQ and -22.9% YoY. YTD is at -5.3% YoY. <a href="https://t.co/DWHR5A5Mpp">pic.twitter.com/DWHR5A5Mpp</a>
&mdash; Roland Pircher (@piloly) <a href="https://twitter.com/piloly/status/1942442683613532254?ref_src=twsrc%5Etfw">July 8, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Why It Matters: The news comes after Tesla recorded a <a href="https://www.benzinga.com/markets/tech/25/07/46239998/dan-ives-hails-teslas-better-than-expected-q2-deliveries-says-fireworks-come-early-for-elon-musk-led-ev-giant">better-than-estimated Q2</a> performance, with the EV giant delivering over 384,122 vehicles in the quarter. The deliveries were largely driven by the Tesla Model 3 and Model Y.
Tesla sales also picked up<a href="https://www.benzinga.com/markets/tech/25/07/46257617/elon-musk-led-tesla-sales-surge-12-in-the-uk-during-june-q2-deliveries-beat-analyst-estimates"> over 12% in the UK</a>, with Elon Musk's company delivering over 7,189 units during Q2 2025, according to sales data released recently.
However, Tesla has had to deal with troubles stemming from Musk's political ambitions with the "America First" party as the company stock fell over 7% in 24 hours. The move has been <a href="https://www.benzinga.com/markets/tech/25/07/46288776/ross-gerber-slams-joke-tesla-board-as-elon-musk-returns-to-politics-dan-ives-says-musk-cannot-start-own-political-party-and-remain-ceo">criticized by experts</a>.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="199" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/08024338/TSLA-JUL-8-2025-1-1024x199.jpg" alt="" class="wp-image-975880" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/08024338/TSLA-JUL-8-2025-1-1024x199.jpg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/08024338/TSLA-JUL-8-2025-1-300x58.jpg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/08024338/TSLA-JUL-8-2025-1-768x149.jpg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/08024338/TSLA-JUL-8-2025-1-1536x298.jpg 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/08024338/TSLA-JUL-8-2025-1.jpg 1552w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Tesla offers satisfactory Momentum and Quality while scoring well on the Growth metric. However, the stock offers poor Value. For more such insights, sign up for<a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound"> Benzinga Edge Stock Rankings</a> today!
Check out more of Benzinga&#8217;s Future Of Mobility coverage by<a href="https://www.benzinga.com/topic/mobility"> following this link.</a>
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/07/46268694/elon-musks-america-party-plans-conflict-with-his-full-time-responsibilities-as-tesla-ceo-says-former-doge-advisor">Elon Musk&#8217;s America Party Plans &#8216;Conflict&#8217; With His Full-Time Responsibilities As Tesla CEO, Says Former DOGE Advisor</a></li>
</ul>
Photo courtesy: Tada Images / Shutterstock.com

Tech

TSLA

Tesla China Sales Plunge Over 75% In First Week Of July Despite Strong Q2 Deliveries

Donald Trump's much-touted plan to sell $5 million "gold card" visas to the ultra-wealthy may never leave the runway, immigration lawyers and policy analysts say.
What Happened: The proposal would create a brand-new residency class for investors willing to wire in billions, but experts note a president cannot invent a visa on his own, according to a <a href="https://www.washingtonpost.com/politics/2025/07/07/trump-gold-card-visa-immigration/">report</a> by The Washington Post. Only Congress can add categories to the Immigration and Nationality Act.
Since February, Trump has waved a laminated prototype at reporters, promised an "immediate rollout," and opened a TrumpCard.gov wait list that Commerce Secretary Howard Lutnick says has attracted <a href="https://www.benzinga.com/news/events/25/06/45967070/howard-lutnick-says-nearly-70000-register-for-5-million-trump-card-visa-as-us-eyes-1-trillion-windfall-from-premium-immigration-plan">nearly 70,000 names</a>. The White House claims the <a href="https://www.benzinga.com/personal-finance/25/03/44237846/trump-proposes-special-a-gold-card-for-wealthy-immigrants-that-costs-5-million-says-selling-enough-could-wipe-out-americas-national-debt">fees could wipe out</a> the $1.3 trillion annual deficit and, eventually, the entire national debt.
But no bill has surfaced on Capitol Hill, and Republican leaders who are already skeptical of expanded immigration paths show "zero appetite" for the idea, said Alex Nowrasteh of the Cato Institute.
See also: <a href="https://www.benzinga.com/news/politics/25/07/46289626/ron-desantis-warns-elon-musk-the-america-party-could-hand-congress-to-democrats-dont-want-to-see-that-happen">Ron DeSantis Warns Elon Musk The &#8216;America Party&#8217; Could Hand Congress To Democrats: &#8216;Don&#8217;t Want To See That Happen&#8217;</a>
Why It Matters: Supreme Court precedent gives Congress "plenary power" over visas, former DHS counsel George Fishman noted. "I'm very dubious it can be done without an act of Congress."
Critics also warn of lawsuits from would-be EB-5 investors, who now wait years after putting in at least $800,000. Former USCIS adviser Doug Rand said opponents will almost certainly challenge any fast-lane plan for newcomers and almost certainly defeat it.
Billionaire Trump donor John Paulson originally proposed the concept as a debt reduction mechanism for America's $36 trillion burden. The program represents a significant shift in targeting high-net-worth individuals. Billionaire Mark Cuban previously <a href="https://www.benzinga.com/25/03/44070799/mark-cuban-supports-trumps-new-gold-card-scheme-if-sold-to-corporations-for-employee-citizenship-have-a-look-at-the-listed-companies-with-most-number-of-immigrants">supported the concept</a> provided corporations buy cards for high-earning employees, while Elon <a href="https://www.benzinga.com/news/25/03/44519944/elons-building-me-the-software-right-now-commerce-secretary-howard-lutnick-says-he-sold-1k-trump-cards-for-5m-each-in-one-day">Musk was involved</a> in developing the application software.
Photo Courtesy: Shutterstock AI
Read next: <a href="https://www.benzinga.com/crypto/25/07/46289599/trump-inaugural-donor-loses-250000-in-crypto-scam-by-steve-witkoff-impersonator-fbi-recovers-over-40000">Trump Inaugural Donor Loses $250,000 In Crypto Scam By Steve Witkoff Impersonator, FBI Recovers Over $40,000</a>

News

Legal

No Fast Lane For The Rich? Lawyers Say Trump's $5 Million 'Gold Card' Visa Can't Fly Without New Law

Zscaler Launches Zero Trust Cellular Platform To Secure IoT and OT Devices Using Just A SIM—No VPN Or Software Required

<ul>
<li>BioSig Technologies, Inc. &nbsp;which recently merged with Streamex Exchange Corporation ("Streamex") to become one of largest public holders of gold bullion.</li>
<li>Streamex' proprietary real-world asset (the "RWA") platform will bring the approx. $142 trillion commodities market on the blockchain powered by Streamex &amp; Solana.</li>
<li>The transaction was led by:
<ul>
<li>Cantor Fitzgerald &amp; Co., Clear Street LLC and Needham &amp; Company, LLC acting as placement agents; and</li>
<li>CIBC World Markets acting as Strategic Advisor to the BSGM board of directors and management.</li>
</ul>
</li>
</ul>

BSGM

Reported Earlier, BioSig And Streamex Announce Up To $1.1B In Growth Financing To Launch Gold-Backed Treasury Strategy And RWA Tokenization Platform

Reported Earlier, Blue Owl Partners With Australia's Koda Capital To Bring OCIC-A Private Credit Income Strategy To Financial Advisors And Clients

Reported Earlier, SunLink Health Systems Hit With NYSE Deficiency Notice For Failing To Hold Annual Shareholder Meeting For Fiscal Year Ending June 30, 2025

AAPG

Reported Earlier, Ascentage Pharma Appoints Dr. Veet Misra As CFO And Eric Huang As SVP Of Global Corporate Development And Finance

Florida Governor Ron DeSantis says Elon Musk should drop his plan for a new "America Party" and instead use his money and clout to force fiscal reforms inside the GOP.
What Happened: "I think Washington needs to be overhauled 100%, but I just don't think a third party is going to do it," DeSantis <a href="https://www.politico.com/news/2025/07/07/trump-musk-feud-desantis-advice-00441519">told</a> reporters after an education event on Monday, according to Politico.
DeSantis, who launched his own 2024 presidential bid in a glitch-filled event with Musk, warned that a third-party candidate would likely result in the Democrats winning all the competitive Senate and House races. &#8220;I'm a Republican. I don't want to see that happen," he said.
He urged Musk to fund state drives for a balanced-budget amendment and congressional term limits, saying the billionaire could have a "monumental impact" by persuading at least 34 legislatures to convene a constitutional convention.
See also: <a href="https://www.benzinga.com/markets/tech/25/07/46288500/elon-musk-may-be-callous-insensitive-and-extremely-cruel-but-black-swan-author-nassim-taleb-is-praying-for-his-safety-amid-rift-with-trump">Elon Musk May Be Callous, Insensitive And &#8216;Extremely Cruel&#8217; But &#8216;Black Swan&#8217; Author Nassim Taleb Is Praying For His Safety Amid Rift With Trump</a>
Musk <a href="https://www.benzinga.com/news/politics/25/07/46265725/elon-musk-announces-formation-of-america-party-emerges-in-wake-of-donald-trumps-historic-spending-bill">unveiled the America Party</a> over the weekend after breaking with President Donald Trump over the mammoth "One Big Beautiful Bill," a tax-and-spending package the Tesla chief calls wasteful. He argues the bill will deepen the deficit and has vowed to bankroll primary challenges against Republicans who backed it.
Why It Matters: DeSantis has neither praised nor condemned the megabill, despite some GOP governors lobbying for its passage. Earlier, he objected to the proposed moratorium on state AI regulations, and negotiators removed it from the final text.
Still, he echoed Musk's complaint that many Republicans "run saying there's out-of-control spending … and they never do it." The governor's counsel comes amid his own fragile reconciliation with Trump after last year's <a href="https://www.benzinga.com/news/24/01/36710200/trump-drops-desanctimonious-nickname-for-ron-desantis-after-florida-governor-exits-2024-presidential">bruising primary feud</a>.
While analysts believe that the Musk-Trump rift and Musk's new party could split the right, DeSantis says structural fixes will rein in Washington. "You have to change the incentives and structures up there. It's within our grasp to do it," he says.
Read next: <a href="https://www.benzinga.com/markets/tech/25/07/46288776/ross-gerber-slams-joke-tesla-board-as-elon-musk-returns-to-politics-dan-ives-says-musk-cannot-start-own-political-party-and-remain-ceo">Ross Gerber Slams &#8216;Joke&#8217; Tesla Board As Elon Musk Returns To Politics, Dan Ives Says Musk Cannot Start Own Political Party &#8216;And Remain CEO&#8217;</a>
Photo Courtesy: Andrew Cline on Shutterstock.com

Politics

Ron DeSantis Warns Elon Musk The 'America Party' Could Hand Congress To Democrats: 'Don't Want To See That Happen'

On Monday, Palantir Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>) co-founder Joe Lonsdale urged a tech-driven transformation of the Food and Drug Administration, warning that bureaucratic inertia is putting the U.S. behind <a href="https://www.benzinga.com/general/biotech/25/03/44107297/china-based-biotech-beigene-scores-fda-approval-for-tevimbra-chemo-combo-for-untreated-patients-with-esophageal-cancer">China in the biotech race</a>.
What Happened: In a blog post, Lonsdale said the FDA's current systems are "sluggish" and outdated, slowing drug approvals and hampering innovation.
To counter this, he announced that the Abundance Institute, in partnership with Stand Together, is raising $4 million to embed 15–20 AI-native engineers, data scientists and product leaders inside the FDA under the Intergovernmental Personnel Act.
"These leaders will remain Abundance employees," Lonsdale said, "but&#8230; wire modern data pipes into legacy silos and automate the mind-numbing paperwork that turns months into years."
Also Read:&nbsp;<a href="https://www.benzinga.com/news/fda/25/06/45945282/sarepta-therapeutics-stock-plummets-over-40-on-second-fatal-case-linked-to-its-gene-therapy" target="_blank" rel="noreferrer noopener">Sarepta Therapeutics Stock Plummets Over 40% On Second Fatal Case Linked To Its Gene Therapy</a>
He compared the effort to special forces units in the military, saying innovation in the defense world happens because nimble, elite special forces teams try key new technology long before adoption by larger forces takes place.
Lonsdale warned the U.S. risks losing global biotech leadership to China, which "is plowing ahead with CRISPR gene therapies and advanced cell therapies," due to fewer regulatory constraints.
"If we let that gap widen," he said, "we will wake up one morning and discover that most of our children's drugs are made in, and controlled by, China."
"Let's boldly push through narrower AI wins that save lives, then expand upon those wins," he concluded, adding, "Let's make the FDA great again."
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">1/ China is racing to dominate the future of medicine. We're bogged down in bureaucracy. That's why friends and I are donating to launch a "special forces" team of elite engineers inside the FDA &#8212; modeled after how the DoD drives innovation. It's time to move faster on cures!
&mdash; Joe Lonsdale (@JTLonsdale) <a href="https://twitter.com/JTLonsdale/status/1942289902252826903?ref_src=twsrc%5Etfw">July 7, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Why It's Important: Last month, the U.S. FDA launched the Commissioner&#8217;s National Priority Voucher (CNPV) program to <a href="https://www.benzinga.com/news/fda/25/06/45982666/fda-introduces-tumor-board-style-reviews-for-faster-drug-decisions">help drug developers</a> fast-track new treatments that align with U.S. national priorities.
The voucher lets companies cut FDA review times from the usual 10–12 months to just 1–2 months by using a new team-based, "tumor board-style" review process with multidisciplinary experts.
The program allows for possible accelerated approval if the product meets requirements.
During the same month, the FDA said it is <a href="https://www.benzinga.com/news/fda/25/06/46101643/did-the-fda-make-a-mistake-sareptas-elevidys-approval-under-scrutiny">investigating reports</a> of fatal acute liver failure linked to Sarepta Therapeutics' (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRPT#NASDAQ">SRPT</a>) gene therapy Elevidys, used to treat Duchenne Muscular Dystrophy in non-ambulatory boys.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/07/46258669/tesla-made-2-76-billion-from-zev-credits-in-2024-in-us-but-trumps-tax-bill-just-killed-this-revenue-stream" target="_blank" rel="noreferrer noopener">Tesla Made $2.76 Billion From ZEV Credits In 2024 In US But Trump&#8217;s Tax Bill Just Killed This Revenue Stream</a></li>
</ul>
Photo Courtesy: Tada Images on Shutterstock.com
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Health Care

PLTR

SRPT

Palantir Co-Founder Joe Lonsdale Wants A FDA Overhaul With Special Forces-Style AI Team Because China Is Racing To Outpace US In Biotech

A donor to the Trump-Vance Inaugural Committee was reportedly defrauded of $250,300 in cryptocurrency. The FBI has recovered $40,300 of the stolen amount, which is now involved in a civil forfeiture case.
What Happened:&nbsp;The victim received an email on Christmas Eve 2024, which appeared to be from Steve Witkoff, co-chair of the Trump-Vance Inaugural Committee. Believing it to be legitimate, the victim transferred 250,300 USDT.ETH—a dollar-pegged stablecoin on the Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) blockchain—to a cryptocurrency wallet controlled by a scammer later traced to Nigeria.
The funds were reportedly laundered within just two hours through multiple wallets, complicating recovery efforts. However, despite the intricate nature of the blockchain transactions, the FBI&#8217;s Washington Field Office managed to trace and recover $40,300 of the stolen cryptocurrency using advanced blockchain analysis.
U.S. Attorney Jeanine Pirro&#8216;s office has filed a civil forfeiture complaint seeking to recover the remaining $210,000. The filing underscores the critical need to verify recipient information before initiating transfers—particularly as cryptocurrency plays a growing role in political fundraising and charitable donations.
SEE ALSO: <a href="https://benzinga.com/crypto/cryptocurrency/25/07/46272572/scottie-pippen-is-watching-bitcoin-xrp-dogecoin-and-what-else" target="_blank" rel="noreferrer noopener">Scottie Pippen Is Watching Bitcoin, XRP, Dogecoin&#8230;And What Else? </a>
Why It Matters:&nbsp;The incident highlights the changing strategies of cybercriminals and the critical need for caution when managing digital assets. This comes in the wake of the U.S. Department of Justice filing&nbsp;a civil forfeiture complaint to&nbsp;claim over $225 million in <a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/46002825/us-seizes-225-million-in-cryptocurrency-tied-to-global-investment-fraud-network">cryptocurrency&nbsp;allegedly</a> connected to international investment fraud schemes. This marked the largest crypto seizure to date involving so-called &#8220;confidence scams.&#8221;
Additionally, crypto hacks and exploits have surged to record levels in the first half of 2025, with total losses exceeding $2.1 billion across at least 75 incidents, according to blockchain intelligence firm TRM Labs. The largest single event was the $1.5 billion hack of Dubai-based crypto exchange Bybit in February, which TRM Labs attributes <a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/46140769/north-korean-hackers-top-crypto-exploits-list-but-another-state-may-surprise-you">to North Korea</a>. This highlights the increasing need for vigilance and security in the cryptocurrency space.
<ul class="wp-block-list">
<li>READ MORE:&nbsp;<a href="https://benzinga.com/crypto/25/07/46288739/trump-memecoin-set-to-launch-on-tron-network-founded-by-chinese-born-billionaire-who-purchased-banana-duct-taped-to-wall-for-6-million" target="_blank" rel="noreferrer noopener">Trump Memecoin Set To Launch On Tron Network Founded By Chinese-Born Billionaire Who Purchased Banana Duct-Taped To Wall For $6 Million &#8211; Benzinga</a></li>
</ul>
 Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

$ETH

Trump Inaugural Donor Loses $250,000 In Crypto Scam By Steve Witkoff Impersonator, FBI Recovers Over $40,000

The CNN Money Fear and Greed index showed a decline in the overall market sentiment, while the index remained in the &#8220;Extreme Greed&#8221; zone on Monday.
U.S. stocks settled lower on Monday, with the Dow Jones index falling more than 400 points during the session after President Donald Trump officially announced sweeping 25% tariffs on all imports from Japan and South Korea, starting Aug. 1. The new tariffs apply to all goods from the two Asian economies and are in addition to any existing sector-specific duties.
Cogent Biosciences Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COGT#NASDAQ">COGT</a>) announced topline results from Part 2 of the SUMMIT trial of bezuclastinib for non-advanced systemic mastocytosis, showing clinically meaningful and statistically significant improvements across the primary and all key secondary endpoints. Core Scientific Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CORZ#NASDAQ">CORZ</a>) shares fell around 18% on Monday after CoreWeave announced plans to acquire the company in an all-stock deal.
Most sectors on the S&amp;P 500 closed on a negative note, with consumer discretionary, materials and energy stocks recording the biggest losses on Monday. However, consumer staples and utilities stocks bucked the overall market trend, closing the session higher.
The Dow Jones closed lower by 422 points to 44,406.36 on Monday. The S&amp;P 500 fell 0.79% to 6,229.98, while the Nasdaq Composite dipped 0.92% to 20,412.52 during Monday's session.
Investors are awaiting earnings results from Penguin Solutions Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PENG#NASDAQ">PENG</a>), Saratoga Investment Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAR#NYSE">SAR</a>) and Kura Sushi USA Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KRUS#NASDAQ">KRUS</a>) today.
What is CNN Business Fear &amp; Greed Index?
At a current reading of 75.1, the index remained in the &#8220;Extreme Greed&#8221; zone on Monday, versus a prior reading of 78.5.
The Fear &amp; Greed Index is a measure of the current market sentiment. It is based on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/price-target/25/07/46271576/5-stock-picks-last-week-from-wall-streets-most-accurate-analysts-8">5 Stock Picks Last Week From Wall Street&#8217;s Most Accurate Analysts</a> </li>
</ul>
Photo courtesy: Shutterstock

Pre-Market Outlook

COGT

Core Scientific, Inc. - Class A Common Stock

CORZ

KRUS

Penguin Solutions, Inc. - Ordinary Shares

PENG

Trump Tariffs Sink Dow Over 400 Points: Investor Sentiment Declines, But Fear & Greed Index Remains In 'Extreme Greed' Zone

President Donald Trump officially signed the <a href="https://www.benzinga.com/markets/tech/25/07/46257394/trumps-big-bautiful-bill-passes-ev-tax-breaks-to-end-on-september-30-what-it-means-for-electric-vehicles">Big Beautiful Bill</a> into law on the Fourth of July and it officially ended the lucrative $7,500 Federal EV credit on all EV purchases. However, the credit is still in effect till September 30. Here's how you can still claim it on your new EV purchase.
How to qualify for the Federal EV Credit
To qualify for the Federal EV credit, you must fulfill certain criteria laid down by the U.S. government's IRS or Internal Revenue Service. The rules suggest that the consumer must buy the EV for personal use and not resale and use the EV within the U.S. primarily.
Also Read: <a href="https://www.benzinga.com/news/politics/25/07/46283137/trump-vs-bezos-how-big-beautiful-bill-may-wreck-20k-ev-dream">Trump Vs. Bezos: How &#8216;Big Beautiful Bill&#8217; May Wreck $20K EV Dream</a>
As far as income is concerned, a single individual must make no more than $150,000 annually to qualify, while heads of households can make up to $225,000 to benefit from the credit.
Couples filing jointly have a $300,000 cap on income for the EV credit. The same limit also applies to surviving spouses, the IRS states.
What vehicles are eligible for the credit
IRS rules state that a vehicle must either be an all-electric, hybrid, or fuel cell vehicle with a battery capacity of at least 7 kilowatt hours and a gross weight of less than 14,000 pounds. Additionally, the vehicle must be manufactured by a qualified automaker.
As far as the price is concerned, a car shouldn't cost more than $55,000 while SUVs, Vans and Pickup trucks can cost no more than $80,000. The vehicles must also undergo assembly within the U.S. to qualify.
Eligible models include the Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) Model Y, Model X, Model 3 and the Cybertruck. It also includes vehicles from General Motors Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>) like the Chevrolet Blazer, Equinox and Silverado, as well as the Cadillac Lyriq and more.
Credit on used EVs and other Information
The credit is also extended to used EVs, with a maximum amount of $4,000 extended on all purchases of eligible used vehicles. Used EVs must also be at least 2 years old and cost no more than $25,000 to be eligible.
Also Read: <a href="https://www.benzinga.com/markets/tech/25/07/46259390/trumps-tax-bill-could-be-a-boost-for-tesla-rivals-rivian-lucid-amid-ev-slowdown-says-bnp-paribas">Trump&#8217;s Tax Bill Could Be A Boost For Tesla-Rivals Rivian, Lucid Amid EV Slowdown, Says BNP Paribas</a>
Most importantly, you must take delivery of your EV before September 30, 2025, to qualify for the EV credit. You won't be eligible for the credit if you place an order before September 30 and take delivery of your vehicle post that date.
Check out more of Benzinga&#8217;s Future Of Mobility coverage by<a href="https://www.benzinga.com/topic/mobility"> following this link.</a>
Read Next:&nbsp;
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/07/46270052/as-trumps-big-beautiful-bill-is-signed-into-law-these-evs-from-tesla-gm-and-ford-will-become-more-expensive">As Trump&#8217;s &#8216;Big, Beautiful Bill&#8217; Is Signed Into Law, These EVs From Tesla, GM And Ford Will Become More Expensive: Report</a></li>
</ul>
Photo courtesy: Shutterstock

Trump's Tax Bill Axes The $7,500 EV Credit: Here's How You Can Still Claim It

With U.S. stock futures trading mixed this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:
<ul class="wp-block-list">
<li>Wall Street expects Penguin Solutions Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PENG#NASDAQ">PENG</a>) to post quarterly earnings at 33 cents per share on revenue of $328.81 million after the closing bell, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. Penguin Solutions shares gained 0.8% to $21.10 in after-hours trading.</li>
<li>Merit Medical Systems Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MMSI#NASDAQ">MMSI</a>) named Martha Aronson as President and CEO and said it sees preliminary second-quarter revenue of $380 million to $384 million. Merit Medical shares gained 4.8% to $95.52 in the after-hours trading session.</li>
<li>Analysts are expecting Saratoga Investment Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAR#NYSE">SAR</a>) to post quarterly earnings at 93 cents per share on revenue of $32.29 million. Saratoga Investment shares gained 0.2% to $25.50 in after-hours trading.</li>
</ul>
Check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
<ul class="wp-block-list">
<li>Ascentage Pharma Group International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPG#NASDAQ">AAPG</a>) named Dr. Veet Misra as Chief Financial Officer and Eric Huang as Senior Vice President of Global Corporate Development and Finance. Ascentage Pharma shares fell 1.9% to close at $42.04 on Monday.</li>
<li>Analysts expect Kura Sushi USA Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KRUS#NASDAQ">KRUS</a>) to post a quarterly loss of 1 cent per share on revenue of $71.83 million. Kura Sushi shares fell 5.4% to close at $85.88 on Monday.</li>
</ul>
Check This Out: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/price-target/25/07/46271576/5-stock-picks-last-week-from-wall-streets-most-accurate-analysts-8">5 Stock Picks Last Week From Wall Street&#8217;s Most Accurate Analysts</a> </li>
</ul>
Photo courtesy: Thapana_Studio via Shutterstock

MMSI

Penguin Solutions, Merit Medical Systems And 3 Stocks To Watch Heading Into Tuesday

Wells Fargo &amp; Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WFC#NYSE">WFC</a>) will release earnings results for the second quarter, before the <a href="https://www.benzinga.com/quote/wfc/earnings">opening bell on Tuesday, July 15.</a>
Analysts expect the San Francisco, California-based company to report quarterly earnings at $1.40 per share, up from $1.33 per share in the year-ago period. Wells Fargo projects to report quarterly revenue of $20.76 billion, compared to $20.69 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On July 1, Wells Fargo said it expects SCB to decrease to 2.5% from 3.8% and intends to raise dividend by 12.5% to 45 cents per share.
Wells Fargo shares fell 1.5% to close at $82.34 on Monday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/wfc/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul class="wp-block-list">
<li>Raymond James analyst David Long downgraded the stock from Strong Buy to Market Perform on July 7, 2025. This analyst has an accuracy rate of 68%.</li>
<li>Citigroup analyst Keith Horowitz maintained a Neutral rating and boosted the price target from $78 to $85 on July 2, 2025. This analyst has an accuracy rate of 79%.</li>
<li>Goldman Sachs analyst Richard Ramsden maintained a Buy rating and boosted the price target from $76 to $86 on June 10, 2025. This analyst has an accuracy rate of 71%.</li>
<li>Piper Sandler analyst Scott Siefers reiterated an Overweight rating and raised the price target from $75 to $85 on June 4, 2025. This analyst has an accuracy rate of 72%.</li>
<li>Evercore ISI Group analyst John Pancari maintained an Outperform rating and boosted the price target from $72 to $88 on June 4, 2025. This analyst has an accuracy rate of 68%</li>
</ul>
Considering buying WFC stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><a href="https://www.benzinga.com/quote/WFC/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="587" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/08023059/image-68-1024x587.png" alt="" class="wp-image-975852" style="width:598px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/08023059/image-68-1024x587.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/08023059/image-68-300x172.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/08023059/image-68-768x440.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/08023059/image-68.png 1130w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/price-target/25/07/46271576/5-stock-picks-last-week-from-wall-streets-most-accurate-analysts-8">5 Stock Picks Last Week From Wall Street&#8217;s Most Accurate Analysts</a> </li>
</ul>
Photo via Shutterstock

Earnings

Price Target

Markets

Analyst Ratings

Trading Ideas

Wells Fargo Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

NEGG

Reported Earlier, Newegg Unveils 11th FantasTech Event Featuring Gaming PCs, Peripherals, And Storage Deals For U.S. And Canadian Shoppers

<ul>
<li>ANKTIVA, a first-in-class, lymphocyte-stimulating agent, works synergistically with BCG to activate and proliferate natural killer (NK) and T cells, helping eliminate cancer</li>
<li>Already approved in the U.S. and designated as a Breakthrough Therapy by the FDA, this marks ANKTIVA's first marketing approval outside the U.S.</li>
<li>ANKTIVA plus BCG offers a new option for eligible patients among the 16,400 to 18,000 people diagnosed with NMIBC in the UK each year</li>
</ul>

IBRX

Reported Earlier, ImmunityBio Gains UK Marketing Authorization for ANKTIVA With Bacillus Calmette-Guérin In Bladder Cancer, Expanding Breakthrough Therapy Beyond U.S

Leading Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) miner Riot Platforms Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIOT#NASDAQ">RIOT</a>) has delivered a strong performance in recent weeks, despite the apex cryptocurrency's price action being somewhat quiet.
What happened: Bitcoin has hovered between $105,000 and $110,000 over the past month, with price movement remaining <a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/46007071/bitcoin-ethereum-xrp-dogecoin-trade-sideways-is-btc-bull-market-entering-its-final-leg">mostly sideways</a> and volatility reduced compared to earlier this year.
In contrast, Riot Platforms' stock has captured investor attention, rising about 14% over the same period.&nbsp;
See Also:<a href="https://www.benzinga.com/25/04/44621245/gold-backed-cryptos-match-yellow-metals-highs-following-trumps-liberation-day-shock"> </a><a href="https://www.benzinga.com/markets/tech/25/07/46284752/coreweave-just-valued-core-scientific-like-its-2021-again">CoreWeave Just Valued Core Scientific Like It&#8217;s 2021 Again</a>
The company released its June 2025 production <a href="https://www.riotplatforms.com/riot-announces-june-2025-production-and-operations-updates/">updates </a>last week, reporting a 76% year-over-year growth in Bitcoin output and a 62% spike in deployed hash rate. On a monthly basis, though, the production declined slightly.&nbsp;
Riot also reduced its all-in power cost by 11% year-over-year, and earned $5.6 million in power credits in June, up 141% from May. 
As of this writing, Riot is the fourth-largest corporate holder of Bitcoin, sitting on a stash worth $2.08 billion, <a href="https://bitcointreasuries.net/">according </a>to Bitcoin Treasuries.net.
<figure class="wp-block-table"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Asset</td>
<td>30-Day Gains +/-</td>
</tr>
<tr>
<td>Bitcoin&nbsp;</td>
<td>+2.47%</td>
</tr>
<tr>
<td>Riot Platforms</td>
<td>+14.13%</td>
</tr>
<tr>
<td>MARA Holdings</td>
<td>+2.95%</td>
</tr>
<tr>
<td>Strategy</td>
<td>+0.91%</td>
</tr>
</tbody>
</table>
</figure>
Other Bitcoin-linked stocks, such as Strategy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) and MARA Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MARA#NASDAQ">MARA</a>), were constrained, growing only 0.91% and 2.95% over the last month.
Price Action:&nbsp; At the time of writing, Bitcoin was exchanging hands at $108,212.62, down 0.80% in the last 24 hours, according to <a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA..">data from Benzinga Pro</a>.
Shares of RIOT were up 0.26% in after-hours trading after sliding 5.09% to $11.55 during Monday&#8217;s regular trading session.
RIOT demonstrated a high momentum score but lagged in Growth as of this writing. Want to see how it compares to Startegy and Mara? Visit <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">Benzinga Edge Stock Rankings</a>.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound"><img loading="lazy" decoding="async" width="443" height="193" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/08020134/image-67.png" alt="" class="wp-image-975810" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/08020134/image-67.png 443w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/08020134/image-67-300x131.png 300w" sizes="(max-width: 443px) 100vw, 443px" /></a></figure>
Photo Courtesy: T. Schneider on Shutterstock.com
Read Next:&nbsp;
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46281239/strategy-launches-4-2-billion-offering-to-fuel-further-bitcoin-accumulation">Strategy Launches $4.2 Billion Offering To Fuel Further Bitcoin Accumulation</a><a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/46148904/donald-trump-says-bitcoin-takes-a-lot-of-pressure-off-the-dollar"> </a></li>
</ul>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BNB

$BTC

$TON

MARA

MSTR

RIOT

Bitcoin Stalls, But Riot Platforms Outperforms With 14% Spike Over 30 Days — Mining Stock Leaves MARA And MSTR Trailing

BKHAU

Reported Earlier, Black Hawk Revises Trust Amendment Proposal To Replace Per-Share Formula With Flat $150K Monthly Extension Deposit

Cathie Wood's Ark Investment Management has filed plans to launch four new exchange-traded funds designed to offer downside protection for investors in its flagship ARK Innovation ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKK#BATS">ARKK</a>), while placing a cap on potential gains.
Check out the current price of&nbsp;<a href="https://www.benzinga.com/quote/ARKK" target="_blank" rel="noreferrer noopener">ARKK stock here.</a>
What Happened: Last week, Ark filed <a href="https://www.sec.gov/Archives/edgar/data/1579982/000121390025061181/ea0247921-01_485apos.htm">with</a> the SEC for four new funds, the ARK Q1, Q2, Q3, and Q4 Defined Innovation ETFs, which will each operate on a rolling 12-month cycle beginning in January, April, July, and October, respectively.
Referred to as &#8220;buffer ETFs,&#8221; they are mostly aimed at limiting potential losses at the firm&#8217;s Ark Innovation ETF to 50%, over their respective timeframes. However, they will only participate in ARKK's gains if the underlying fund rises more than about 5% over that same period, according to a report by Reuters.
See Also: <a href="https://www.benzinga.com/news/25/07/46211529/cathie-wood-doubles-down-on-tesla-amid-elon-musks-feud-with-trump-sells-3-million-worth-of-coinbase-stock">Cathie Wood Doubles Down On Tesla Amid Elon Musk&#8217;s Feud With Trump, Sells $3 Million Worth Of Coinbase Stock</a>
This marks Ark&#8217;s entry into the growing buffer ETF market, which has been gaining traction in recent years as investors seek a more measured approach to equity market volatility.
<figure class="wp-block-table"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td class="has-text-align-center" data-align="center">Newly Launched Buffer ETF Name (Ticker)</td>
</tr>
<tr>
<td class="has-text-align-center" data-align="center">ARK Q1 Defined Innovation ETF (ARKI)</td>
</tr>
<tr>
<td class="has-text-align-center" data-align="center">ARK Q2 Defined Innovation ETF (ARKJ)</td>
</tr>
<tr>
<td class="has-text-align-center" data-align="center">ARK Q3 Defined Innovation ETF (ARKL)</td>
</tr>
<tr>
<td class="has-text-align-center" data-align="center">ARK Q4 Defined Innovation ETF (ARKM)</td>
</tr>
</tbody>
</table>
</figure>
With this, the Ark joins the ranks of BlackRock Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLK#NYSE">BLK</a>), Allianz SE (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ALIZF#OTC">ALIZF</a>) and Innovator ETFs by Capital Management LLC, which have several such products in the market.
According to Eric Balchunas, senior ETF analyst at Bloomberg Intelligence, &#8220;These are like Diet Ark. Investors are probably telling them, &#8216;we like the taste and the kick but would like to trim the caffeine and sugar.'&#8221;
&#8220;So maybe they would like to give up a touch of upside for some sleep at night for the downside,&#8221; Balchunas says, as reported <a href="https://www.bloomberg.com/news/articles/2025-07-07/cathie-wood-targets-investor-jitters-with-diet-ark-buffer-etfs">by</a> Bloomberg.
<figure class="wp-block-table"> 
<table class="has-fixed-layout">
<thead>
<tr>
<th class="has-text-align-center" data-align="center">Company</th>
<th class="has-text-align-center" data-align="center">Portfolio Weight</th>
<th class="has-text-align-center" data-align="center">2025 YTD Return</th>
</tr>
</thead>
<tbody>
<tr>
<td class="has-text-align-center" data-align="center">Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>)</td>
<td class="has-text-align-center" data-align="center">9.89%</td>
<td class="has-text-align-center" data-align="center">-22.50%</td>
</tr>
<tr>
<td class="has-text-align-center" data-align="center">Coinbase Global Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>)</td>
<td class="has-text-align-center" data-align="center">8.48%</td>
<td class="has-text-align-center" data-align="center">+38.84%</td>
</tr>
<tr>
<td class="has-text-align-center" data-align="center">Roku Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROKU#NASDAQ">ROKU</a>)</td>
<td class="has-text-align-center" data-align="center">7.65%</td>
<td class="has-text-align-center" data-align="center">+18.22%</td>
</tr>
<tr>
<td class="has-text-align-center" data-align="center">Roblox Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBLX#NYSE">RBLX</a>)</td>
<td class="has-text-align-center" data-align="center">6.41%</td>
<td class="has-text-align-center" data-align="center">+83.14%</td>
</tr>
<tr>
<td class="has-text-align-center" data-align="center">CRISPR Therapeutics AG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRSP#NASDAQ">CRSP</a>)</td>
<td class="has-text-align-center" data-align="center">5.41%</td>
<td class="has-text-align-center" data-align="center">+23.53%</td>
</tr>
<tr>
<td class="has-text-align-center" data-align="center">Robinhood Markets Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>)</td>
<td class="has-text-align-center" data-align="center">5.40%</td>
<td class="has-text-align-center" data-align="center">+136.97%</td>
</tr>
<tr>
<td class="has-text-align-center" data-align="center">Circle Internet Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRCL#NYSE">CRCL</a>)</td>
<td class="has-text-align-center" data-align="center">4.80%</td>
<td class="has-text-align-center" data-align="center">+149.26%</td>
</tr>
<tr>
<td class="has-text-align-center" data-align="center">Shopify Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHOP#NASDAQ">SHOP</a>)</td>
<td class="has-text-align-center" data-align="center">4.71%</td>
<td class="has-text-align-center" data-align="center">+8.49%</td>
</tr>
<tr>
<td class="has-text-align-center" data-align="center">Tempus AI Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEM#NASDAQ">TEM</a>)</td>
<td class="has-text-align-center" data-align="center">4.63%</td>
<td class="has-text-align-center" data-align="center">+69.37%</td>
</tr>
<tr>
<td class="has-text-align-center" data-align="center">Palantir Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>)</td>
<td class="has-text-align-center" data-align="center">4.15%</td>
<td class="has-text-align-center" data-align="center">+85.02%</td>
</tr>
</tbody>
</table>
</figure>
Why It Matters: Last week, Proshares <a href="https://www.benzinga.com/etfs/new-etfs/25/07/46208362/proshares-launches-etfs-that-reset-daily-so-you-dont-have-to-panic-when-markets-are-choppy">launched buffer ETFs</a> that reset daily, without lock-in periods that last for an entire year. The fund house employs a patent-pending methodology that protects investors from daily drawdowns, while still providing exposure to potential gains.
Ark&#8217;s funds have been <a href="https://www.benzinga.com/etfs/specialty-etfs/25/06/45804512/trump-musk-feud-gets-ugly-etfs-exposed-with-tesla-caught-in-the-crossfire">caught in the crossfire</a> in recent months, particularly due to its exposure to Tesla, which witnessed sharp drawdowns in response to the ongoing feud between CEO Elon Musk and President Donald Trump. The buffer ETFs are aimed at protecting investors from such volatility.
This kind of protection is particularly suited for the Ark Innovation ETF, given its exposure to speculative and disruptive technologies. In 2022, the fund witnessed a steep 66.9% pullback owing to the same. 
Price Action: The Ark Innovation ETF was down 0.91% on Monday, trading at $70.44 and is up 0.06% after hours.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound"><img loading="lazy" decoding="async" width="1024" height="193" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/08013955/Screenshot-2025-07-08-at-11.09.37-AM-1024x193.png" alt="" class="wp-image-975787" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/08013955/Screenshot-2025-07-08-at-11.09.37-AM-1024x193.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/08013955/Screenshot-2025-07-08-at-11.09.37-AM-300x57.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/08013955/Screenshot-2025-07-08-at-11.09.37-AM-768x145.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/08013955/Screenshot-2025-07-08-at-11.09.37-AM.png 1176w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
According to Benzinga&#8217;s Edge Stock Rankings, the Ark Innovation ETF has an unfavorable price trend in the short, medium and long terms, but how does it compare with other related ETFs? Click <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">here</a> to find out more.
Photo courtesy: ChrisStock82 / Shutterstock.com
Read More: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/25/07/46267760/cathie-wood-questions-big-movement-in-old-bitcoin-part-of-a-government-settlement-deal">Cathie Wood Questions Big Movement In Old Bitcoin: &#8216;Part Of A Government Settlement Deal?&#8217;</a></li>
</ul>

Specialty ETFs

Options

ETFs

Allianz Ag Muenchen Namen-Akt Vinkuliert Shares

ALIZF

ARKK

COIN

CRCL

CRSP

HOOD

RBLX

ROKU

SHOP

Cathie Wood-Led Ark Launches Buffer ETFs For Its Flagship ARKK, Analyst Says It's Like Diet Soda — 50% Loss Protection, But There's A Catch

FLNC

Reported Earlier, Fluence Selected By AMPYR Australia For 300 MW / 600 MWh Wellington Battery Project With Full Suite Of Intelligent Storage Solutions

Press Releases

General

Organogenesis Reports Positive Interim Analysis of Second Phase 3 Clinical Trial of ReNu for Knee Osteoarthritis

Organogenesis Holdings Inc. Announces $130 Million Private Placement Offering of Series A Convertible Preferred Stock

Organogenesis Holdings Inc. Reports Third Quarter 2024 Financial Results

Financing

Organogenesis Commends Final LCDs

Organogenesis Expands Manufacturing Capacity to Support Future Growth

Organogenesis Holdings Inc. to Report Fourth Quarter of Fiscal Year 2024 Financial Results on February 27, 2025

Organogenesis Holdings Inc. Reports Fourth Quarter 2024 Financial Results

Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025

Organogenesis Supports CMS' Local Coverage Determination Implementation Delay to Review Coverage Policies to Maintain Patient Access with High Quality Evidence of Effectiveness

Comments

Organogenesis Holdings

Notizie

Ultime notizie per Organogenesis Holdings (NASDAQ:ORGO) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO